What this site is for
This is a patient decision guide to polycaprolactone, published by Chongqing West District Hospital, a tertiary general hospital in Jiulongpo District, Chongqing. It exists for the person deciding rather than the person studying: what the carrier and the scaffold each do, how long the wait is, what a course asks of them in visits and months, what the nodule risk means in practice, and when the honest answer is a different treatment or none.
What it deliberately does not do
It does not name products or brands, quote prices or dosages, or promise a result. It does not present a course as a lift, does not describe it as natural without also describing its irreversibility, and does not repeat the class-by-class explanation that the collagen biostimulator site and the injectables hub already carry.
The two facts behind every page
The volume visible on the day is the carrier, and the effect that persists is the scaffold your tissue builds around. And nothing dissolves this substance, so an uneven result is managed over time rather than switched off. Both are stated wherever treatment is described, because a patient who understands them from the beginning makes a different and better decision.
How the content is reviewed and corrected
Ke He, MD, Deputy Director and Head of Skin & Laser Aesthetics, is the responsible physician. Every guide is reviewed against her clinical judgement before publication and reviewed again on a twelve-month cycle. If you find something unclear, out of date or wrong, the contact page explains how to tell us, and corrections are made to the page itself.